Uni-Bio Science Group (HKSE:00690) ROCE % : 24.99% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Uni-Bio Science Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Uni-Bio Science Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 24.99%.

Uni-Bio Science Group ROCE % Historical Data

The historical data trend for Uni-Bio Science Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uni-Bio Science Group ROCE % Chart

Uni-Bio Science Group Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

2.65

-32.64

-10.63

23.13

30.83

Uni-Bio Science Group Semi-Annual Data
	Sep14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															17.12	29.07	40.47	24.99	48.65

Uni-Bio Science Group ROCE % Calculation

Uni-Bio Science Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	76.683	/	( ( (292.471 - 90.255)	+	(409.992 - 114.79) )	/ 2 )
	=	76.683	/	( (202.216	+	295.202)	/ 2 )
	=	76.683	/	248.709
	=	30.83 %

Uni-Bio Science Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	65.722	/	( ( (311.282 - 80.413)	+	(409.992 - 114.79) )	/ 2 )
	=	65.722	/	( ( 230.869	+	295.202 )	/ 2 )
	=	65.722	/	263.0355
	=	24.99 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Uni-Bio Science Group (HKSE:00690) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Uni-Bio Science Group ROCE % Related Terms

Thank you for viewing the detailed overview of Uni-Bio Science Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Uni-Bio Science Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Uni-Bio Science Group Ltd (HKSE:00690) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG

Website

https://www.uni-bioscience.com

Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.

Executives

Automatic Result Limited
Mjkpc Holdings Limited
Leung Kingsley
Century Ally Ventures Limited	2201 Interest of corporation controlled by you
Fih (bvi) Limited	2201 Interest of corporation controlled by you
Petite Arbre Limited	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd.	2301 Trustee
Xjg Capital Management Limited	2201 Interest of corporation controlled by you
Yau Kwok Wing Tony	2201 Interest of corporation controlled by you
Lau Kan Sum	2307 Founder of a discretionary trust who can infl
Credit Suisse Trust Limited	2301 Trustee
Mjkpc Holdings Limited	2201 Interest of corporation controlled by you

Uni-Bio Science Group Headlines

No Headlines